Concepedia

Hejin Jia

HJ

6

Publications

980

Citations

6

H-Index

2016

Active since

Affiliations

Chinese PLA General Hospital(Current)

Hejin Jia is an author at Chinese PLA General Hospital specializing in oncology, cancer therapeutics, and immunotherapy.

Top concepts

Publications per year

2016–2022

6

Publications

6

Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia

Hanren Dai, Zhiqiang Wu, Hejin Jia et al. · Journal of Hematology & Oncology · 2020 · 312 citations · Full text

Chimeric antigen receptor-modified T cells for the immunotherapy of patients with EGFR-expressing advanced relapsed/refractory non-small cell lung cancer

Kaichao Feng, Yelei Guo, Hanren Dai et al. · Science China Life Sciences · 2016 · 277 citations · Full text

, , +16

Phase I Study of Chimeric Antigen Receptor–Modified T Cells in Patients with EGFR-Positive Advanced Biliary Tract Cancers

Yelei Guo, Kaichao Feng, Yang Liu et al. · Clinical Cancer Research · 2017 · 245 citations

Haploidentical CD19/CD22 bispecific CAR-T cells induced MRD-negative remission in a patient with relapsed and refractory adult B-ALL after haploidentical hematopoietic stem cell transplantation

Hejin Jia, Zhenguang Wang, Yao Wang et al. · Journal of Hematology & Oncology · 2019 · 61 citations · Full text

Increased IFNγ+ T Cells Are Responsible for the Clinical Responses of Low-Dose DNA-Demethylating Agent Decitabine Antitumor Therapy

Xiang Li, Yan Zhang, Meixia Chen et al. · Clinical Cancer Research · 2017 · 57 citations · Full text

, , +16

Rows per page

1–5 of 6